Form 4 for AEON AEON Biopharma, Inc.
Accepted 2025-05-23 00:00:00 ET · period of report 2025-05-21 · accession 0001610717-25-000129 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-23 | 2025-05-21 | AEON | FISCHER JOST | Dir | P - Purchase | $0.49 | +60.0K | 266.8K | +29% | +$29.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-05-21 | P | A | 60,000 | $0.49 | 266,785 | D | — | — | (F1) This transaction was executed in multiple trades in prices ranging from $0.4659 to $0.4999, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. |